Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (321-330 of 325) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 325 results.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling studyChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Plos One|March 19, 2025
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdensChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Administration and Policy in Mental Health|November 8, 2023
COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the PandemicVicki Fung, Julie H Levison, Anna Wilson, et al.
Disability and Health Journal|June 15, 2024
Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and/or developmental disabilitiesJulie H Levison, Vicki Fung, Anna Wilson, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 33

Showing results (321-330 of 325) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 325 results.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling studyChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Plos One|March 19, 2025
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdensChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Administration and Policy in Mental Health|November 8, 2023
COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the PandemicVicki Fung, Julie H Levison, Anna Wilson, et al.
Disability and Health Journal|June 15, 2024
Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and/or developmental disabilitiesJulie H Levison, Vicki Fung, Anna Wilson, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 33